Phase I study of everolimus (RAD001) and AMG 479 in patients (pts) with advanced solid tumors and colorectal cancer (CRC).

被引:0
|
作者
Khawaja, M. R.
Younger, A.
Funke, J. M.
Waddell, M. J.
Jones, D. R.
Pollok, K.
Prasad, N. K.
Berry, W.
Sandusky, G.
Chiorean, E. G.
机构
[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[2] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
[3] Indiana Univ, Indianapolis, IN 46204 USA
关键词
D O I
10.1200/jco.2011.29.15_suppl.tps157
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS157
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer
    Taekyu Lim
    Jeeyun Lee
    Duk Joo Lee
    Ha Yeon Lee
    Boram Han
    Kyung Kee Baek
    Hee Kyung Ahn
    Su Jin Lee
    Se Hoon Park
    Joon Oh Park
    Young Suk Park
    Ho Yeong Lim
    Kyoung-Mee Kim
    Won Ki Kang
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 255 - 262
  • [32] A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer
    Moulder, Stacy
    Gladish, Gregory
    Ensor, Joe
    Gonzalez-Angulo, Ana Maria
    Cristofanilli, Massimo
    Murray, James L.
    Booser, Daniel
    Giordano, Sharon H.
    Brewster, Abeena
    Moore, Julia
    Rivera, Edgardo
    Hortobagyi, Gabriel N.
    Tran, Hai T.
    CANCER, 2012, 118 (09) : 2378 - 2384
  • [33] A phase I-II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors
    Schoffski, P.
    Reichardt, P.
    Blay, J-Y
    Dumez, H.
    Morgan, J. A.
    Ray-Coquard, I.
    Hollaender, N.
    Jappe, A.
    Demetri, G. D.
    ANNALS OF ONCOLOGY, 2010, 21 (10) : 1990 - 1998
  • [34] Efficacy of RAD001 (everolimus) against advanced gastric cancer with peritoneal dissemination
    Fumiko Taguchi
    Yasuo Kodera
    Yasufumi Katanasaka
    Kazuyoshi Yanagihara
    Tomohide Tamura
    Fumiaki Koizumi
    Investigational New Drugs, 2011, 29 : 1198 - 1205
  • [35] Dose-finding study of pegylated liposomal doxorubicin (PLD) and the mTOR inhibitor RAD001 (R) in patients (pts) with advanced solid tumors
    Sessa, C.
    Perotti, A.
    Delmonte, A.
    Del Conte, G.
    Gallerani, E.
    Fasolo, A.
    Zanaboni, F.
    Locatelli, A.
    Dall'O, E.
    Gianni, L.
    EJC SUPPLEMENTS, 2008, 6 (12): : 104 - 104
  • [36] Efficacy of RAD001 (everolimus) against advanced gastric cancer with peritoneal dissemination
    Taguchi, Fumiko
    Kodera, Yasuo
    Katanasaka, Yasufumi
    Yanagihara, Kazuyoshi
    Tamura, Tomohide
    Koizumi, Fumiaki
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (06) : 1198 - 1205
  • [37] Targeted therapy in Multiple Myeloma: Results of first phase I study with everolimus (RAD001)
    Guenther, A.
    Baumann, P.
    Burger, R.
    Klapper, W.
    Schmidmaier, R.
    Gramatzki, M.
    ONKOLOGIE, 2010, 33 : 94 - 94
  • [38] Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients
    Su Jin Lee
    Jongtae Lee
    Jeeyun Lee
    Se Hoon Park
    Joon Oh Park
    Young Suk Park
    Ho Yeong Lim
    Kyoung-Mee Kim
    In-Gu Do
    Sin-Ho Jung
    Dong-Seok Yim
    Won Ki Kang
    Investigational New Drugs, 2013, 31 : 1580 - 1586
  • [39] Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients
    Lee, Su Jin
    Lee, Jongtae
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kim, Kyoung-Mee
    Do, In-Gu
    Jung, Sin-Ho
    Yim, Dong-Seok
    Kang, Won Ki
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (06) : 1580 - 1586
  • [40] Phase II Study of Everolimus (RAD001) in Previously Treated Small Cell Lung Cancer
    Tarhini, Ahmad
    Kotsakis, Athanasios
    Gooding, William
    Shuai, Yongli
    Petro, Daniel
    Friedland, David
    Belani, Chandra P.
    Dacic, Sanja
    Argiris, Athanassios
    CLINICAL CANCER RESEARCH, 2010, 16 (23) : 5900 - 5907